Peijia Medical Ltd
HKEX:9996
Net Margin
Peijia Medical Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
CN |
P
|
Peijia Medical Ltd
HKEX:9996
|
4.3B HKD |
-37%
|
|
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
231.5B USD |
32%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
191.5B USD |
28%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
154.7B USD |
12%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
149.2B USD |
12%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
110.5B USD |
14%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
52.5B EUR |
9%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
48.7B USD |
7%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
45.4B USD |
75%
|
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
42.6B USD |
23%
|
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
275.8B CNY |
31%
|
Peijia Medical Ltd
Glance View
Peijia Medical Ltd. engages in the manufacture and sale of medical devices. The company is headquartered in Suzhou, Jiangsu. The company went IPO on 2020-05-15. Through its subsidiaries, the Company operates two segments. Transcatheter Valve Therapeutic Business segment is mainly engaged in the development of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is engaged in the research and development of neurointerventional procedural medical devices. The firm's main products under development include TaurusOne, TaurusElite, TaurusNXT and others. The firm operates its businesses primarily in domestic market.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Peijia Medical Ltd's most recent financial statements, the company has Net Margin of -36.8%.